| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 2733-54-2 | Benzenesulfonamide,4-amino-N-(4,5-dihydro-1H-imidazol-2-yl)-; Sulfanilamide,N1-2-imidazolidinylidene- (7CI,8CI); Sulfanilamide, N1-2-imidazolin-2-yl- (6CI) |  | C9H12N4O2S | 詳情 | 供應商 | |
| 3814-80-0 | Hydrazinecarbothioamide,2-[[3-hydroxy-5-(hydroxymethyl)-2-methyl-4-pyridinyl]methylene]-; Pyridoxal,thiosemicarbazone (6CI,7CI,8CI); NSC 47407; Pyridoxal monothiosemicarbazone |  | C9H12N4O2S | 詳情 | 供應商 | |
| 6466-41-7 | 1H-Purine-2,6-dione,3,9-dihydro-8-(1-mercaptoethyl)-1,3-dimethyl-; Theophylline,8-(1-mercaptoethyl)- (7CI,8CI); NSC 95864 |  | C9H12N4O2S | 詳情 | 供應商 | |
| 105828-94-2 | Thiazole,2-methyl-5-[[2-(nitromethylene)-1-imidazolidinyl]methyl]- |  | C9H12N4O2S | 詳情 | 供應商 | |
| 31895-48-4 | Thiazolo[4,5-d]pyrimidine-5,7(4H,6H)-dione,2-(ethylamino)-4,6-dimethyl- |  | C9H12N4O2S | 詳情 | 供應商 | |
| 335403-18-4 | 1H-Purine-2,6-dione,7-ethyl-3,7,8,9-tetrahydro-1,3-dimethyl-8-thioxo- |  | C9H12N4O2S | 詳情 | 供應商 | |
| 6466-42-8 | 1H-Purine-2,6-dione,3,9-dihydro-8-(2-mercaptoethyl)-1,3-dimethyl-; Theophylline,8-(2-mercaptoethyl)- (7CI,8CI); NSC 95865 |  | C9H12N4O2S | 詳情 | 供應商 | |
| 6466-39-3 | 1H-Purine-2,6-dione,3,9-dihydro-1,3-dimethyl-8-[(methylthio)methyl]-; Theophylline,8-[(methylthio)methyl]- (7CI,8CI); NSC 518807 |  | C9H12N4O2S | 詳情 | 供應商 | |
| 104151-98-6 | 2-Butenediamide,N1-(5-propyl-1,3,4-thiadiazol-2-yl)-; 2-Butenediamide,N-(5-propyl-1,3,4-thiadiazol-2-yl)- (9CI) |  | C9H12N4O2S | 詳情 | 供應商 | |
| 107089-80-5 | 4H-1,2,4-Benzothiadiazine,4-ethyl-3-hydrazinyl-, 1,1-dioxide; 2H-1,2,4-Benzothiadiazin-3(4H)-one,4-ethyl-, hydrazone, 1,1-dioxide (9CI); NSC 373859 |  | C9H12N4O2S | 詳情 | 供應商 | |
| 64484-44-2 | 5H-1,3,4-Thiadiazolo[3,2-a][1,3,5]triazine-5,7(6H)-dione,2-(1,1-dimethylethyl)-6-methyl- |  | C9H12N4O2S | 詳情 | 供應商 | |